Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 20, 2017
Mitsui Chemicals announced the development of XSP series of Chemipearl which is a high performance “Water-based Heat Seal Coating” for pharmaceutical blister packaging.
read more
Tuesday, November 21, 2017
Mitsubishi Tanabe Pharma America announced the appointment of Kevin O'Brien as Vice President of Market Access and a member of the organization's executive leadership team.
read more
Certara®, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp® ...
read more
Thursday, September 13, 2018
Mitra Biotech announced a partnership with Glenmark Pharmaceuticals focused on advancing Glenmark's proprietary immuno-oncology drug pipeline utilizing Mitra's CANscript platform.
read more
Mission has raised $15m in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer.
read more
Mispro Biotech Services announced expansion of its network of vivarium research facilities with the opening of an 18,000-square-foot facility in Broad Hollow Bioscience Park in Farmingdale, NY.
read more
Thursday, January 30, 2025
miRecule and GBI Biomanufacturing announced a strategic partnership to advance the development and clinical supply of miRecule's innovative Antibody-RNA Conjugate (ARC) based products.
read more
Tuesday, January 05, 2021
miRagen has gained exclusive rights to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend Fc technology from Xencor.
read more
Monday, February 26, 2018
Minerva Biotechnologies announced a European distribution agreement with CellSystems GmbH a European life science supplier, for AlphaSTEM Naïve Stem Cell Culture System.
read more
Tuesday, January 25, 2022
Mindset Pharma Inc. has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug ...
read more
Thursday, August 03, 2023
Mind Medicine announced that it has entered into a license agreement with Catalent to access the company’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
MilliporeSigma and Schneider Electric announced the signing of a MoU that aims to automate biopharmaceutical processes for China’s biopharmaceutical industry.
read more
Wednesday, November 01, 2017
MilliporeSigma announced the signing of a MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
read more
Thursday, August 02, 2018
MilliporeSigma and InnoCore Pharmaceuticals have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer platform.
read more